Clinical Trial Update: Safety and Efficacy Study in Acute Ischaemic Stroke [Phase 2]

View source ↗

Summary

Phase 2 safety and efficacy trial in acute ischemic stroke has been completed, sponsored by Vernalis (R&D) Ltd.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Snippet

Sponsor: Vernalis (R&D) Ltd | Conditions: Stroke | Phase 2 | Status: COMPLETED